Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-08-18
2008-11-11
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S469000, C548S494000, C548S495000, C514S415000, C514S419000, C546S268100, C546S276400, C544S336000, C544S358000, C544S359000
Reexamination Certificate
active
07449489
ABSTRACT:
The invention relates to a group of novel indole compounds of Formula (I): wherein: R1, R2, R4, R6, R6a, R7, R8, R9, R10, and A are as defined in the specification, which are useful as gonadotrophin releasing hormone antagonists. The invention also relates to pharmaceutical formulations of said compounds, methods of treatment using said compounds and to processes for the preparation of said compounds.
REFERENCES:
patent: 6809098 (2004-10-01), Wardleworth et al.
patent: 97/21435 (1997-06-01), None
patent: 97/21703 (1997-06-01), None
patent: WO 97/21435 (1997-06-01), None
patent: WO 97/21703 (1997-06-01), None
patent: WO 97/21704 (1997-06-01), None
patent: WO 97/21707 (1997-06-01), None
patent: WO 98/55116 (1998-12-01), None
patent: WO 98/55119 (1998-12-01), None
patent: WO 98/55123 (1998-12-01), None
patent: WO 98/55470 (1998-12-01), None
patent: WO 98/55479 (1998-12-01), None
patent: 99/20599 (1999-04-01), None
patent: WO 99/20599 (1999-04-01), None
patent: WO 99/21553 (1999-05-01), None
patent: WO 99/21557 (1999-05-01), None
patent: WO 99/41251 (1999-08-01), None
patent: WO 99/41252 (1999-08-01), None
patent: WO 99/51231 (1999-10-01), None
patent: WO 99/51232 (1999-10-01), None
patent: WO 99/51233 (1999-10-01), None
patent: WO 99/51234 (1999-10-01), None
patent: WO 99/51595 (1999-10-01), None
patent: WO 99/51596 (1999-10-01), None
patent: WO 00/04013 (2000-01-01), None
patent: WO 00/53178 (2000-08-01), None
patent: WO 00/53179 (2000-08-01), None
patent: WO 00/53180 (2000-08-01), None
patent: WO 00/53181 (2000-08-01), None
patent: WO 00/53185 (2000-08-01), None
patent: WO 00/53602 (2000-08-01), None
patent: WO 02/66459 (2002-08-01), None
patent: 02/092565 (2002-11-01), None
patent: WO 00/69433 (2002-11-01), None
patent: WO 02/92565 (2002-11-01), None
Ashton et al ‘Substituted Indole-5-carboxamides and -acetamides as Potent Nonpeptide GnRH Receptor Antagonist.’ Bioorganic & Medicinal Chemistry Letters 2001, vol. 11, pp. 1723-1726.
Ashton et al ‘Potent Nonpeptide GnHR Receptor Antagonists Derived from Substituted Indole-5-carboxamides and -acetamides Bearing a Pyridine Side-Chain Terminus.’ Bioorganic & Medicinal Chemistry Letters 2001, vol. 11, pp. 1727-1731.
Ashton et al ‘Orally Bioavailable, Indole-Based Nonpeptide GnHR Receptor Antagonists with High Potancy and Functional Activity.’ Bioorganic and medicinal Chemistry Letters 2001, vol. 11, pp. 2597-2602.
Chu et al. ‘initial Structure-Activity Relationship of a Noval Class of Nonpeptidyl GnHR Receptor Antagonists: 2-Arylindoles.’ Bioorganic and Medicinal Chemistry Letters 2001, vol. 11, pp. 509-513.
Chu et al. ‘SAR Studies of novel 5-Substituted 2-Arylindoles as Nonpeptidyl GnHR Receptor Antagonists.’ Bioorganic and Medicinal Chemistry Letters 2001, vol. 11, pp. 515-517.
Freidinger, R. M. ‘Nonpeptide ligands for peptide and protein receptors.’ Current Opinion in Chemical Biology 1999, vol. 3, pp. 395-406.
Goulet, M. T. ‘Gonadotropin Releasing Hormone Antagonists.’ Annual Reports in Medicinal Chemistry 1995, vol. 30, pp. 169-178.
Lin et al. ‘2-(3,5-Dimethylphenyl)tryptamine Derivatives That Bind to the GnHR Receptor.’ Bioorganic & Medicinal Chemistry Letters 2001, vol. 11, pp. 1073-1076.
Lin et al. ‘Heterocyclic Derivatives of 2-(3,5-Dimethylphenyl)tryptamine as GnHR Receptor Antagonists.’ Bioorganic & Medicinal Chemistry Letters 2001, vol. 11, pp. 1077-1080.
Simoene, J. P. ‘Synthesis of chiral β-methyl tryptamine-derived GnHR antagonists.’ Tetrahedron Letters 2001, vol. 42, pp. 6459-6461.
Walsh et al. ‘A convergent synthesis of (S)-β-methyl-2-aryltryptamine based gonadotropin releasing hormone antagonists.’ Tetrahedron, 2001, vol. 57, pp. 5233-5241.
Young et al. ‘2-Arylindoles as Gonadotropin Releasing Hormone (GnHR) Antagonists: Optimization of the Tryptamine Side Chain.’ Bioorganic & Medicinal Chemistry Letters, 2002, vol. 12, pp. 827-832.
Ujjainwalla, F. ‘Total synthesis of 6- and 7-azaindole derived GnHR antagonists.’ Tetrahedron Letters, 2001, vol. 42, pp. 6441-6445.
Simeone, J. P et al. ‘Modification of the Pyridine Moiety of Non-peptidyl Indole GnHR Receptor Antagonists.’ Bioorganic & Medicinal Chemistry Letters, 2002, vol. 12, pp. 3329-3332.
Gibbs, J. B. ‘Pharmaceutical Research in Molecular Onocology.’ Cell, 1994, vol. 79, pp. 193-198.
Boyle Francis Thomas
Davies Robert
Matusiak Zbigniew
Wardleworth Michael
AstraZeneca AB
Shameem Golam M
LandOfFree
Indolylalkylamino-methylidenecarbamate derivatives useful as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indolylalkylamino-methylidenecarbamate derivatives useful as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolylalkylamino-methylidenecarbamate derivatives useful as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4021230